Acute myocardial infarction. Predictors of mortality at a public hospital in the city of Fortaleza, Ceará State;Infarto agudo do miocárdio. Preditores de mortalidade em hospital público em Fortaleza, Ceará

Arquivos Brasileiros de Cardiologia

Volumn 80, Issue 6, 2003, Pages 607-620

  Ribeiro, Demóstenes Gonçalves Lima ^a,b   De Andrade, Pedro José Negreiros ^a   Paes Jr , José Nogueira ^a   Saraiva, Lurildo Ribeiro ^a  

^a Hospital de Messejana   (Brazil)

^b NONE   (Brazil)

Author keywords

Diabetes mellitus; Elderly; In hospital mortality; Killip functional class; Myocardial infarction

Indexed keywords

STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; HEART RIGHT VENTRICLE; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; ONSET AGE; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX; ST SEGMENT; SYMPTOM; TOBACCO; ARTERIOSCLEROSIS; BRAZIL; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGY; HEART INFARCTION; MIDDLE AGED; SMOKING; TIME;

AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; BRAZIL; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; EPIDEMIOLOGIC METHODS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SMOKING; TIME FACTORS;

EID: 0141705526     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x2003000600004     Document Type: Article

References (41)

1. Lee KL, Woodlief LH, Topol EJ, et al. Predictors of 30 day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41021 patients. Circulation 1995; 91: 1659-68.
2. McGovern PG, Pankow JS, Shahar E, et al. The Minnesota Heart Survey Investigators. Recent trends in acute coronary heart disease. N Engl J Med 1996; 334: 884-90.
3. Marcopito LF, Shirassu MM. Mortalidade por infarto agudo do miocárdio e pelas demais doenças isquêmicas do coração no Estado de São Paulo, 1980 - 1996. Arq Bras Cardiol 2000; 75; 69-71.
4. Moraes AS, Rezende MHV, Freitas ICM. Tendência da mortalidade por doença isquêmica do coração no Município de Coiânia - Brasil na série histórica entre 1980 e 1994. Arq Bras Cardiol 2000; 74: 493-7.
5. Passos LCS, Lopes AA, Lessa I, et al. Tendência da mortalidade por infarto agudo do miocárdio (1981 a 1996) na Cidade de Salvador, Brasil. Arq Bras Cardiol 2000; 74: 329-31.
6. Segunda diretriz da Sociedade Brasileira de Cardiologia para o tratamento do infarto agudo do miocárdio. Arq Bras Cardiol 2000; 74: 7-18.
7. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1996; 28: 1328-428.
8. Grundy SM. Primary prevention of coronary heart disease. Integrating risk assessment with intervention. Circulation 1999; 100: 988-98.
9. th ed. Philadelphia: WB Saunders 1997: 108-52.
10. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit: a two year experience with 250 patients. Am J Cardiol 1967; 20: 457-64.
11. nd ed. New York. John Wiley & Sons 2000.
12. Kannel WB, Sorlie P, McNamara PM. Prognosis after initial myocardial infarction: the Framingham Study. Am J Cardiol 1979; 44: 53-9.
13. Becker RC, Terrin M, Ross R, et al. Comparison of clinical outcomes for women and men after acute myocardial infarction. Ann Intern Med 1994; 120: 638-45.
14. Pimenta L, Bassan R, Potsch A, et al. É o sexo feminino um preditor independente de mortalidade hospitalar no infarto agudo do miocárdio? Arq Bras Cardiol 2000; 77: 37-43.
15. Greenland P, Reicher-Reiss H, Goldbourt U, et al. In-hospital and 1-year mortality in 1524 women after myocardial infarction. Comparison with 4315 men. Circulation 1991; 83: 484-91.
16. Vaccarino V, Parsons L, Every RN, et al. Sex-based differences in early mortality after myocardial infarction. The National Registry of Myocardial Infarction 2 Participants. N Engl J Med 1999; 341: 217-25.
17. Hochman JS, Tamis JE, Thompson DT, et al. Sex, clinical presentation and outcome in patients with acute coronary syndromes. The global use of strategies to open occluded coronary arteries in acute coronary syndromes IIb Investigators. N Engl J Med 1999; 341: 226-32.
18. White HD, Barbash GI, Modan M, et al. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen ctivator/Streptokinase Mortality Study. Circulation 1993; 88: 2097-103.
19. Lincoff AM, Califf RM, Ellis SG, et al. Thrombolytic therapy for women with myocardial infarction: is there a gender gap? Thrombolysis and Angioplasty in Myocardial Infarction Study Group. J Am Coll Cardiol 1993; 22: 1780-7.
20. Mehilli J, Kastrati A, Dirschinger J, et al. Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA 2002; 287: 210-5.
21. McMechan SR, Adgey AAJ. Age related outcome in acute myocardial infarction: elderly people benefit from thrombolysis and should be included in trials. BMJ 1998; 317: 1334-5.
22. Marcus FI, Friday K, McCans J, et al. Age-related prognosis after acute myocardial infarction (The Multicenter Diltiazem Post-Infarction Trial). Am J Cardiol 1990; 65: 559-66.
23. Barakat K, Wilkinson P, Deaner A, et al. How should age affect management of acute myocardial infarction? A Prospective Cohort Study. Lancet 1999; 353: 955-9.
24. Devlin W, Cragg D, Jacks M, et al. Comparison of outcome in patients with acute myocardial infarction aged > 75 years with that in younger patients. Am J Cardiol 1995; 75: 573-6.
25. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Lancet 1994; 343: 11-22.
26. Goldberg RJ, Mooradd M, Gurwirtz JH, et al. Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The Second National Registry of Myocardial Infarction). Am J Cardiol 1998; 82: 259-64.
27. Piegas LS, Rossi Neto JM. Consenso de trombólise e pós-trombólise. In: Timermann A, Machado César LA, Ferreira JFM, Bertolami MC (Ed.) Manual de Cardiologia: SOCESP. Atheneu, 2000: 182-5.
28. Carvalho AC, Gonçalves Jr, I. Trombolítico endovenoso: uso atual e perspectivas futuras. Rev Soc Cardiol Estado de São Paulo 2001; 11: VI-XXVIII.
29. Solomon SD, Ridker PM, Antman EM. Ventricular arrhythimias in trials of thrombolytic therapy for acute myocardial infarction: a meta-analysis. Circulation 1993; 88: 2575-81.
30. Canto JG, Every NR, Magid DJ, et al. The volume of primary angioplasty procedures and survival after acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. N Engl J Med 2000; 342: 1573-80.
31. Gottlieb S, Gouldbourt U, Boyko V, et al. Improved Outcome of Elderly Patients (= or > 75 Years of Age) with Acute Myocardial Infarction From 1981-1983 to 1992-1994 in Israel. The SPRINT and Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israel Nifedipine Trial. Circulation 1997; 95: 342-50.
32. Andrikopoulos GK, Richter DJ, Dilaveris PE, et al. In-hospital mortality of habitual cigarette smokers after acute myocardial infarction. The "smoker's paradox" in a countrywide study. Eur Heart J 2001; 22: 776-84.
33. Grines CL, Topol EJ, O'Neill WW, et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995; 91: 298-303.
34. Barret-Connor E, Orchard T. Insulin dependent diabetes mellitus and ischemic heart disease. Diabetes Care 1985; 8: 65-70.
35. Nesto RW, Zarich S. Acute myocardial infarction in diabetes mellitus - Lessons Learned From ACE Inhibition. Circulation 1998; 97: 12-5.
36. Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773-8.
37. Hands ME, Lloyd BL, Robinson JS, et al. Prognostic significance of electrocardiographic site of infarction after correction for enzymatic size of infarction. Circulation 1986; 73: 885-91.
38. Zehender M, Kasper W, Kauder E, et al. Right ventricular infarction as an independent predictor of prognosis after acute inferior myocardial infarction. N Engl J Med 1993; 328: 981-8.
39. Boden WE, McKay RG. Optimal treatment of acute coronary syndromes - an evolving strategy. N Engl J Med 2001; 344: 1939-42.
40. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein IIb/IIIa Inhibition with coronary stenting for acute myocardial infarction. Admiral Investigators. N Engl J Med 2001; 344: 1895-903.
41. De Jaegcre PP, Simoons ML. Immediate angioplasty: a conservative view from Europe: cost effectiveness needs to be considered. Br Heart J 1995; 73: 407-8.